BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Canavesi E, Alfieri C, Pelusi S, Valenti L. Hepcidin and HFE protein: Iron metabolism as a target for the anemia of chronic kidney disease. World J Nephrol 2012; 1(6): 166-176 [PMID: 24175256 DOI: 10.5527/wjn.v1.i6.166]
URL: https://www.wjgnet.com/2220-6124/full/v1/i6/166.htm
Number Citing Articles
1
Dalila Cunha Oliveira, Amanda Nogueira-Pedro, Ed Wilson Santos, Araceli Hastreiter, Graziela Batista Silva, Primavera Borelli, Ricardo Ambrósio Fock. A review of select minerals influencing the haematopoietic processNutrition Research Reviews 2018; 31(2): 267 doi: 10.1017/S0954422418000112
2
Violeta Dopsaj, Aleksandra Topić, Miljan Savković, Neda Milinković, Ivana Novaković, Danica Ćujić, Sanja Simić-Ogrizović. Associations of Common Variants in HFE and TMPRSS6 Genes with Hepcidin-25 and Iron Status Parameters in Patients with End-Stage Renal DiseaseDisease Markers 2019; 2019: 1 doi: 10.1155/2019/4864370
3
Luca Valenti, Alessandro Maloberti, Stefano Signorini, Marta Milano, Francesca Cesana, Fabrizio Cappellini, Paola Dongiovanni, Marianna Porzio, Francesco Soriano, Maura Brambilla, Giancarlo Cesana, Paolo Brambilla, Cristina Giannattasio, Silvia Fargion, Kostas Pantopoulos. Iron Stores, Hepcidin, and Aortic Stiffness in Individuals with HypertensionPLOS ONE 2015; 10(8): e0134635 doi: 10.1371/journal.pone.0134635
4
Alexandre Reuben, Jacqueline W. Chung, Réjean Lapointe, Manuela M. Santos. The hemochromatosis protein HFE 20 years later: An emerging role in antigen presentation and in the immune systemImmunity, Inflammation and Disease 2017; 5(3): 218 doi: 10.1002/iid3.158
5
Kristina Petrulienė, Edita Žiginskienė, Vytautas Kuzminskis, Irena Nedzelskienė, Inga Arūnė Bumblytė. Hepcidin serum levels and resistance to recombinant human erythropoietin therapy in hemodialysis patientsMedicina 2017; 53(2): 90 doi: 10.1016/j.medici.2017.03.001
6
Jürgen Floege, Felix Funk, Markus Ketteler, Anjay Rastogi, Sebastian Walpen, Adrian C Covic, Stuart M Sprague. Iron kinetics following treatment with sucroferric oxyhydroxide or ferric citrate in healthy rats and models of anaemia, iron overload or inflammationNephrology Dialysis Transplantation 2020; 35(6): 946 doi: 10.1093/ndt/gfaa030
7
Lucile Mercadel, Marie Metzger, Jean Philippe Haymann, Eric Thervet, Jean-Jacques Boffa, Martin Flamant, François Vrtovsnik, Pascal Houillier, Marc Froissart, Bénédicte Stengel, Jaap A. Joles. The Relation of Hepcidin to Iron Disorders, Inflammation and Hemoglobin in Chronic Kidney DiseasePLoS ONE 2014; 9(6): e99781 doi: 10.1371/journal.pone.0099781
8
Gerhard Rogler, Stephan Vavricka. Anemia in Inflammatory Bowel Disease: An Under-Estimated Problem?Frontiers in Medicine 2015; 1 doi: 10.3389/fmed.2014.00058
9
Chen Yueying, Wang Yu Fan, Shen Jun. Anemia and iron deficiency in Crohn’s diseaseExpert Review of Gastroenterology & Hepatology 2020; 14(3): 155 doi: 10.1080/17474124.2020.1732817
10
J. C. Fernandes, P. Garrido, S. Ribeiro, P. Rocha-Pereira, E. Bronze-da-Rocha, L. Belo, E. Costa, F. Reis, A. Santos-Silva. Iron as the Key Modulator of Hepcidin Expression in Erythroid Antibody-Mediated HypoplasiaBioMed Research International 2014; 2014: 1 doi: 10.1155/2014/421304
11
Zeki Aydin, Meltem Gursu, Serhat Karadag, Sami Uzun, Abdullah Sumnu, Yasemin Doventas, Savas Ozturk, Rumeyza Kazancioglu. The relationship of Prohepcidin levels with anemia and inflammatory markers in non-diabetic uremic patients: a controlled studyRenal Failure 2014; 36(8): 1253 doi: 10.3109/0886022X.2014.937663
12
Sandra Ribeiro, Luís Belo, Flávio Reis, Alice Santos-Silva. Iron therapy in chronic kidney disease: Recent changes, benefits and risksBlood Reviews 2016; 30(1): 65 doi: 10.1016/j.blre.2015.07.006
13
Patrícia Garrido, Sandra Ribeiro, João Fernandes, Helena Vala, Petronila Rocha-Pereira, Elsa Bronze-da-Rocha, Luís Belo, Elísio Costa, Alice Santos-Silva, Flávio Reis. Resistance to Recombinant Human Erythropoietin Therapy in a Rat Model of Chronic Kidney Disease Associated AnemiaInternational Journal of Molecular Sciences 2015; 17(1): 28 doi: 10.3390/ijms17010028
14
HUADING LU, LIYI LIAN, DEHAI SHI, HUIQING ZHAO, YUHU DAI. Hepcidin promotes osteogenic differentiation through the bone morphogenetic protein 2/small mothers against decapentaplegic and mitogen-activated protein kinase/P38 signaling pathways in mesenchymal stem cellsMolecular Medicine Reports 2015; 11(1): 143 doi: 10.3892/mmr.2014.2769
15
Han Li, Su-Juan Feng, Lu-Lu Su, Wei Wang, Xiao-Dong Zhang, Shi-Xiang Wang. Serum Hepcidin Predicts Uremic Accelerated Atherosclerosis in Chronic Hemodialysis Patients with Diabetic NephropathyChinese Medical Journal 2015; 128(10): 1351 doi: 10.4103/0366-6999.156781
16
Ashwani K Gupta, Waseem David, Zoran Ivanovic. Does Erythropoietin Cause Hemoglobin Variability- Is It ‘Normal’?PLoS ONE 2014; 9(4): e92890 doi: 10.1371/journal.pone.0092890
17
Adrian C. Covic, Jürgen Floege, Markus Ketteler, Stuart M. Sprague, Laura Lisk, Viatcheslav Rakov, Anjay Rastogi. Iron-related parameters in dialysis patients treated with sucroferric oxyhydroxideNephrology Dialysis Transplantation 2016; : gfw242 doi: 10.1093/ndt/gfw242
18
Junichi Fujii, Takujiro Homma, Sho Kobayashi, Prashant Warang, Manisha Madkaikar, Malay B. Mukherjee. Erythrocytes as a preferential target of oxidative stress in bloodFree Radical Research 2021; 55(8): 781 doi: 10.1080/10715762.2021.1873318
19
Luca Valenti, Serena Pelusi. HFE mutations and iron in hemodialysis patientsHemodialysis International 2017; 21: S47 doi: 10.1111/hdi.12541
20
Junichi Fujii. Ascorbate is a multifunctional micronutrient whose synthesis is lacking in primatesJournal of Clinical Biochemistry and Nutrition 2021; 69(1): 1 doi: 10.3164/jcbn.20-181
21
Norio Suzuki, Masayuki Yamamoto. Roles of renal erythropoietin-producing (REP) cells in the maintenance of systemic oxygen homeostasisPflügers Archiv - European Journal of Physiology 2016; 468(1): 3 doi: 10.1007/s00424-015-1740-2